In the realm of gene therapeutics, nucleic acid-based therapies have become pivotal, with plasmid DNA (pDNA) emerging as a key player in DNA vaccines and gene therapy products. As the interest in pDNA for vaccination and therapeutic purposes grows, the need for efficient plasmid manufacturing processes becomes increasingly pressing. A crucial aspect of this manufacturing is downstream processing, particularly the isolation and purification of pDNA. To meet regulatory standards, pDNA must be obtained as a highly purified, homogeneous preparation of supercoiled pDNA (sc pDNA), presenting a significant challenge due to the diverse molecules present in the producer organism.
In a recent study, novel chromatographic prototypes were evaluated for their potential in adsorption and selective polishing of sc pDNA. The study involved conducting batch and column assays using different resins to optimize pDNA adsorption conditions, including exploring electrostatic and hydrophobic interactions by varying factors such as ionic strength, pH, and contact time. The selected resins were further analyzed for their binding capacities, selectivity towards sc pDNA, and removal of impurities like genomic DNA, endotoxins, and proteins to characterize the final quality of sc pDNA. The results indicated promising potential in using agmatine- and arginine-based resins for sc pDNA polishing, with both resins demonstrating high binding capacities for pDNA and excellent purity levels above 90% for sc pDNA.
Chromatographic purification of pDNA is a critical step in obtaining pharmaceutical-grade products for gene therapy and biopharmaceutical applications. Various chromatographic methods have been employed for pDNA purification, with ion-exchange chromatography being the most widely used due to the rapid binding between the negatively charged phosphate groups in pDNA and positively charged groups on anion exchange resins. However, traditional chromatographic resins present limitations in purifying pDNA effectively due to slow mass transfer, low binding capacity, long processing times, and low resolution of isoforms. Hence, there is a demand for novel chromatographic resins to enhance pDNA purification processes and overcome current limitations.
The study conducted extensive screenings and optimization processes to determine the optimal conditions for pDNA adsorption and elution using the novel chromatographic prototypes. The pH and contact time were found to significantly impact pDNA adsorption, with different prototypes showing varying preferences for pH levels and contact times. By carefully adjusting the ionic strength in the elution buffer and exploring different elution conditions, the study successfully improved pDNA recovery rates, with some prototypes exhibiting higher binding capacities and more efficient elution profiles. The Langmuir model was utilized to characterize the static binding capacity of the prototypes, providing insights into the strength of the interactions between pDNA and the chromatographic resins.
The findings from the static binding capacity assays revealed that prototype 1 exhibited the highest binding capacity, indicating its potential as a promising resin for pDNA purification. The Langmuir constant values further elucidated the differences in binding capacities between the prototypes, with prototype 1 showing a lower constant value, suggesting easier elution compared to prototype 14. The study highlighted the importance of considering the ionic capacity of the resins in achieving optimal pDNA binding and elution characteristics, with variations in resin chemistry impacting the maximum adsorption capacities.
Overall, the research on optimizing chromatographic prototypes for supercoiled plasmid DNA purification presents a significant advancement in the field of gene therapy and biopharmaceutical production. By addressing the challenges associated with traditional chromatographic resins and exploring novel interactions for pDNA adsorption and elution, the study offers valuable insights into enhancing the efficiency and purity of pDNA purification processes. Further investigations into the scalability and robustness of these optimized conditions could pave the way for streamlined and cost-effective purification methods for pDNA-based therapeutics.
Takeaways:
– Novel chromatographic prototypes show promising potential for supercoiled plasmid DNA polishing
– pH and contact time optimization significantly impact pDNA adsorption and elution
– Understanding static binding capacity and Langmuir constants is crucial for resin selection and elution efficiency
– Consideration of ionic capacity and resin chemistry plays a key role in optimizing pDNA purification processes
Tags: protein purification, chromatography, regulatory, yeast, filtration, clinical trials, gene therapy, downstream
Read more on pmc.ncbi.nlm.nih.gov